• Conference Recording
  • On-Demand
  • Pharmacotherapy
This session will examine the use of on-label anti-obesity pharmacotherapy to treat obesity.
  • 1.25 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Physical Activity
Join Dr. Carolynn Francavilla and Stephanie Burke, both level 1 CrossFit Coaches, in this session where we look past BMI and see the inner athlete in everyone.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Behavioral Modification
OMA 2023 Spring Summit: Do Sleepy Brains Make Poor Food & Other Lifestyle Choices? Impact of Sleep on Weight Management (On Demand)CME/CE Expiration Date: 4/23/26
  • 0.75 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Nutrition Therapy
Obesity with sarcopenia poses a dual health concern especially in aging populations.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Pharmacotherapy
OMA 2023 Spring Summit: Overcoming Barriers to Initiating Anti-Obesity Medications (On Demand)CME/CE Expiration Date: 4/23/26
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Nutrition Therapy
In this presentation I will discuss the physiology of human body weight regulation and how our bodies adapt to various changes in diet, including the amount of calories, carbs versus fat, as well a
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Behavioral Modification
description hereThis presentation will enable clinicians to apply practical applications of cognitive behavioural therapy skills in obesity management.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Special Populations
Obesity is a disease that disproportionately affects women. Those from ethnic/racial minorities and those who live in poverty are often more severely affected.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Special Populations
In this session, speaker will deliver current endocrine society guidelines on gender affirming therapies and the association of obesity with high dose reproductive hormone initiation.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Pharmacotherapy
A core component of obesity treatment includes recognition of weight promoting medications and their alternatives.
  • 1.00 AMA PRA Category 1 Credit

Pages